Purchase

Recombinant Human EMR1/ADGRE1/(F4/80) protein (rFc Tag)

Species

Human

Purity

>90 %, SDS-PAGE

Tag

rFc Tag

Activity

not tested

Cat no : Eg1716


Product Information

Purity >90 %, SDS-PAGE
Endotoxin <1.0 EU/μg protein, LAL method
Activity
Not tested
Expression HEK293-derived Human EMR1/ADGRE1/(F4/80) protein His21-Asp599 (Accession# Q14246-1) with a rabbit IgG Fc tag at the C-terminus.
GeneID 2015
Accession Q14246-1
PredictedSize 89.4 kDa
SDS-PAGE
Formulation Lyophilized from sterile PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization.
Reconstitution Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water.
Storage Conditions
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
  • Until expiry date, -20℃ to -80℃ as lyophilized proteins.
  • 3 months, -20℃ to -80℃ under sterile conditions after reconstitution.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature.

Background

EMR1 (EGF-like module containing mucin-like hormone receptor 1), also known as Adhesion G protein-coupled receptor E1 (ADGRE1), is a surface receptor with seven transmembrane segments that belong to the EGF-7-transmembrane family of G protein-coupled receptors. EMR1 expression is restricted to eosinophilic granulocytes, where expression is overlapping with the eotaxin receptor CCR3 and the immunoglobulin-like lectin Siglec-8. Absence on other leukocytes, including basophils, implies that EMR1 is a highly specific marker for eosinophils in humans and may be used as a novel therapeutic target for eosinophilic disorders. F4/80, the murine homolog of EMR1, is a marker of murine macrophage.

References:

1. Kwakkenbos, Mark J et al. Immunogenetics vol. 55,10 (2004): 655-66. 2. Baud, V et al. Genomics vol. 26,2 (1995): 334-44. 3. Hamann, Jörg et al. European journal of immunology vol. 37,10 (2007): 2797-802. 4. Legrand, Fanny et al. The Journal of allergy and clinical immunology vol. 133,5 (2014): 1439-47, 1447.e1-8. 5. Austyn, J M, and S Gordon. European journal of immunology vol. 11,10 (1981): 805-15.